207 related articles for article (PubMed ID: 32392203)
1. [Design of an Efficient Inhibitor for the Influenza A Virus M2 Ion Channel].
Vorobjev YN
Mol Biol (Mosk); 2020; 54(2):321-332. PubMed ID: 32392203
[TBL] [Abstract][Full Text] [Related]
2. An effective molecular blocker of ion channel of M2 protein as anti-influenza a drug.
Vorobjev YN
J Biomol Struct Dyn; 2021 Apr; 39(7):2352-2363. PubMed ID: 32212957
[TBL] [Abstract][Full Text] [Related]
3. Viral M2 ion channel protein: a promising target for anti-influenza drug discovery.
Moorthy NS; Poongavanam V; Pratheepa V
Mini Rev Med Chem; 2014; 14(10):819-30. PubMed ID: 25342196
[TBL] [Abstract][Full Text] [Related]
4. Design and pharmacological characterization of inhibitors of amantadine-resistant mutants of the M2 ion channel of influenza A virus.
Balannik V; Wang J; Ohigashi Y; Jing X; Magavern E; Lamb RA; Degrado WF; Pinto LH
Biochemistry; 2009 Dec; 48(50):11872-82. PubMed ID: 19905033
[TBL] [Abstract][Full Text] [Related]
5. How amantadine and rimantadine inhibit proton transport in the M2 protein channel.
Intharathep P; Laohpongspaisan C; Rungrotmongkol T; Loisruangsin A; Malaisree M; Decha P; Aruksakunwong O; Chuenpennit K; Kaiyawet N; Sompornpisut P; Pianwanit S; Hannongbua S
J Mol Graph Model; 2008 Oct; 27(3):342-8. PubMed ID: 18620883
[TBL] [Abstract][Full Text] [Related]
6. An M2-V27A channel blocker demonstrates potent in vitro and in vivo antiviral activities against amantadine-sensitive and -resistant influenza A viruses.
Hu Y; Musharrafieh R; Ma C; Zhang J; Smee DF; DeGrado WF; Wang J
Antiviral Res; 2017 Apr; 140():45-54. PubMed ID: 28087313
[TBL] [Abstract][Full Text] [Related]
7. Functional studies indicate amantadine binds to the pore of the influenza A virus M2 proton-selective ion channel.
Jing X; Ma C; Ohigashi Y; Oliveira FA; Jardetzky TS; Pinto LH; Lamb RA
Proc Natl Acad Sci U S A; 2008 Aug; 105(31):10967-72. PubMed ID: 18669647
[TBL] [Abstract][Full Text] [Related]
8. Designing inhibitors of M2 proton channel against H1N1 swine influenza virus.
Du QS; Huang RB; Wang SQ; Chou KC
PLoS One; 2010 Feb; 5(2):e9388. PubMed ID: 20186344
[TBL] [Abstract][Full Text] [Related]
9. Influenza a virus M2 ion channel activity is essential for efficient replication in tissue culture.
Takeda M; Pekosz A; Shuck K; Pinto LH; Lamb RA
J Virol; 2002 Feb; 76(3):1391-9. PubMed ID: 11773413
[TBL] [Abstract][Full Text] [Related]
10. Channel activity of mirror-image M2 proton channel of influenza A virus is blocked by achiral or chiral inhibitors.
Guo QY; Zhang LH; Zuo C; Huang DL; Wang ZA; Zheng JS; Tian CL
Protein Cell; 2019 Mar; 10(3):211-216. PubMed ID: 29679235
[No Abstract] [Full Text] [Related]
11. Structure and inhibition of the drug-resistant S31N mutant of the M2 ion channel of influenza A virus.
Wang J; Wu Y; Ma C; Fiorin G; Wang J; Pinto LH; Lamb RA; Klein ML; Degrado WF
Proc Natl Acad Sci U S A; 2013 Jan; 110(4):1315-20. PubMed ID: 23302696
[TBL] [Abstract][Full Text] [Related]
12. Characterization of inhibition of M2 ion channel activity by BL-1743, an inhibitor of influenza A virus.
Tu Q; Pinto LH; Luo G; Shaughnessy MA; Mullaney D; Kurtz S; Krystal M; Lamb RA
J Virol; 1996 Jul; 70(7):4246-52. PubMed ID: 8676445
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of pinanamine derivatives as anti-influenza A M2 ion channel inhibitors.
Zhao X; Jie Y; Rosenberg MR; Wan J; Zeng S; Cui W; Xiao Y; Li Z; Tu Z; Casarotto MG; Hu W
Antiviral Res; 2012 Nov; 96(2):91-9. PubMed ID: 22982118
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of Action of Novel Influenza A/M2 Viroporin Inhibitors Derived from Hexamethylene Amiloride.
Jalily PH; Eldstrom J; Miller SC; Kwan DC; Tai SS; Chou D; Niikura M; Tietjen I; Fedida D
Mol Pharmacol; 2016 Aug; 90(2):80-95. PubMed ID: 27193582
[TBL] [Abstract][Full Text] [Related]
15. Discovery of Potent Antivirals against Amantadine-Resistant Influenza A Viruses by Targeting the M2-S31N Proton Channel.
Li F; Ma C; Hu Y; Wang Y; Wang J
ACS Infect Dis; 2016 Oct; 2(10):726-733. PubMed ID: 27657178
[TBL] [Abstract][Full Text] [Related]
16. Structural and energetic analysis of drug inhibition of the influenza A M2 proton channel.
Gu RX; Liu LA; Wei DQ
Trends Pharmacol Sci; 2013 Oct; 34(10):571-80. PubMed ID: 24011996
[TBL] [Abstract][Full Text] [Related]
17. Structure of the amantadine binding site of influenza M2 proton channels in lipid bilayers.
Cady SD; Schmidt-Rohr K; Wang J; Soto CS; Degrado WF; Hong M
Nature; 2010 Feb; 463(7281):689-92. PubMed ID: 20130653
[TBL] [Abstract][Full Text] [Related]
18. 3-Azatetracyclo[5.2.1.1(5,8).0(1,5)]undecane derivatives: from wild-type inhibitors of the M2 ion channel of influenza A virus to derivatives with potent activity against the V27A mutant.
Rey-Carrizo M; Torres E; Ma C; Barniol-Xicota M; Wang J; Wu Y; Naesens L; DeGrado WF; Lamb RA; Pinto LH; Vázquez S
J Med Chem; 2013 Nov; 56(22):9265-74. PubMed ID: 24237039
[TBL] [Abstract][Full Text] [Related]
19. Virtual Screening Identifies Chebulagic Acid as an Inhibitor of the M2(S31N) Viral Ion Channel and Influenza A Virus.
Duncan MC; Onguéné PA; Kihara I; Nebangwa DN; Naidu ME; Williams DE; Balgi AD; Andrae-Marobela K; Roberge M; Andersen RJ; Niikura M; Ntie-Kang F; Tietjen I
Molecules; 2020 Jun; 25(12):. PubMed ID: 32599753
[TBL] [Abstract][Full Text] [Related]
20. Analysis by metadynamics simulation of binding pathway of influenza virus M2 channel blockers.
Sakai Y; Kawaguchi A; Nagata K; Hirokawa T
Microbiol Immunol; 2018 Jan; 62(1):34-43. PubMed ID: 29210473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
